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Light has a significant influence on sleep behaviors by influencing the circadian regulation of 
sleep-wake rhythms, the sleep homeostat, and through direct alerting effects. Melanopsin, the 
circadian photopigment discovered within intrinsically-photosensitive retinal ganglion cells 
(ipRGCs), detects environmental irradiance levels and is needed to process non-visual light 
information. Although a growing animal literature demonstrates the importance of melanopsin 
for sleep-wake timing and behavioral responses to light, little is known about its role in human 
sleep regulation. Preliminary evidence in healthy adults suggests that the P10L variant in the 
melanopsin gene (OPN4) interacts with day length to predict variations in self-reported sleep 
time (Roecklein et al. 2012). The present study aimed to replicate these findings in a larger 
sample while also using actigraphy to behaviorally quantify sleep characteristics. We 
hypothesized that variation in OPN4 single nucleotide polymorphisms (SNPs; P10L and I394T) 
would be associated with differences in sleep timing and sleep duration as a function of day 
length. Participants were healthy, midlife community volunteers (N= 377; mean age 42.43 ± 7.37 
years old, 50.4% Female; 100% Non-Hispanic Caucasian). Participants wore actigraphy 
monitors over a course of 7 nights. Day length on the first date of actigraphy assessment was 
determined by the U.S. Naval Observatory (2010). Linear regression analyses revealed that P10L 
and I394T were both not significantly associated with the timing of sleep onset, wake onset or 
sleep duration. There was no main effect of day length or an interaction effect between day 
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length and either polymorphism. Our findings suggest there may be no association between these 
genetic variants and behavioral sleep timing in a largely healthy population. Given insufficient 
power in the present study, however, and the different sleep assessment used in comparison to 
previous reports, it remains to be determined if a functional impact of these polymorphisms 
exists.  
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1.0  INTRODUCTION 
Sleep disturbances have been linked to numerous chronic health illnesses, psychiatric disorders, 
diminished overall functioning, and all-cause morbidity (Foley, Ancoli-Israel, Britz, & Walsh, 
2004; Ford & Cooper-Patrick, 2001; Meisinger, Heier, & Loewel, 2005; Nilsson, Nilsson, 
Hedblad, & Berglund, 2001). Although there is a large body of evidence supporting the 
increased risk of various health diseases associated with sleep disturbances, the biological 
mechanisms underlying disrupted sleep processes remain elusive. Efforts are needed to first 
understand the pathways contributing to naturally occurring variability in sleep timing and length 
within healthy populations.  
The environmental 24-hour light-dark cycle is fundamental for coordinating the 
biological and physiological rhythms of processes such as the sleep-wake cycle. Non-visual light 
information is sent from the retina to various brain structures including regions involved in sleep 
and circadian regulation (Figure 1). The model shown in Figure 1 is simplified for our purposes, 
while more complex neural interactions involved in sleep behaviors are reviewed elsewhere (see 
Pace-Schott & Hobson, 2002; Saper, Scammell, & Lu, 2005; Hubbard et al., 2013). As shown in 
Figure 1, light information is sent through the retinohypothalamic tract or the non-image forming 
(NIF) pathway to hypothalamic nuclei such as the suprachiasmatic nucleus (SCN; the central 
clock) and intergeniculate leaflet (IGL) to entrain circadian rhythms. The ipRGCs both indirectly 
(via the SCN) and directly project to the ventrolateral preoptic area (VLPO). Other brain regions 
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that have direct projections from ipRGCs include the lateral hypothalamus and 
subparaventricular zone (SPZ). These nuclei are connected to ascending and descending neural 
pathways that together maintain wake and sleep states (Saper, Chou, & Scammell, 2001). For 
instance, the SCN projects to the pineal gland and coordinates the release of melatonin, a sleep-
promoting hormone that is secreted in darkness. In addition, activation of neurons in the VLPO 
inhibits the arousal-promoting neurons that elicit wakefulness. Retinal projections also lead to 
the superior colliculus (SC) of the midbrain, a region important for saccadic eye movements and 
implicated in certain light influenced sleep behaviors (described in detail below). Originating 
from retinal projection pathways, the influence of light on sleep behaviors can be divided into 
three types of pathways: 1) circadian photoentrainment involving retinal projections to the SCN, 
2) pathways independent of the circadian clock that influence the homeostatic sleep drive, and 3) 
direct retinal projections to various sleep-promoting regions that influence alertness. Given 
recent advances in knowledge about the pathways mediating non-visual light responses, studying 
a component of the non-visual light pathway may improve our understanding of the circadian 
and light-related neurobiology of normal and abnormal sleep regulation.  
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Figure 1. Schematic of Non-Visual Light Input Pathways that influence sleep behaviors.  
The depicted pathways are simplified to demonstrate that melanopsin may play a role in several 
pathways.1= Circadian Pathways; 2= Circadian-Independent Pathways; 3 = Direct projects to 
sleep-promoting brain regions. IGL = intergeniculate leaflet; SCN = suprachiasmatic nucleus; 
vSPZ = ventral subparaventricular zone; VLPO = ventrolateral preoptic area; SC = superior 
colliculus. 
1.1 INFLUENCE OF LIGHT ON SLEEP 
1.1.1 Circadian 
The first pathway through which light input influences sleep is through the circadian 
coordination of sleep-wake behaviors. Circadian rhythms are physiological and behavioral 
processes, such as the sleep-wake cycle, that demonstrate oscillations of roughly 24 hours and 
are coordinated primarily by the central clock located in the suprachiasmatic nuclei (SCN; Klein, 
Moore, & Reeper, 1991). Although circadian regulated behaviors have self-sustaining properties 
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such that there remains a rhythm when isolated from environmental stimuli, these rhythms 
deviate from the regular 24 hour cycle (Aschoff, 1978). The solar light-dark cycle serves as the 
primary environmental cue, known as a zeitgeber that entrains the central clock (Aschoff, 1978) 
and consequently contributes in part to human sleep and wake timing. The two-process model of 
sleep (Borbély, 1982) posits that the sleep-wake cycle is regulated by both circadian factors and 
a homeostatic drive (i.e. buildup of sleep debt). Specifically, sleep duration is regulated by an 
interaction between the homeostatic and circadian factors while sleep timing is thought to be a 
function of circadian peak in arousal that may be modified by accumulated sleep debt (Dijk, 
Duff, Riel, Shanahan, & Czeisler, 2000; Dijk & Czeisler, 1995). Given that light is the primary 
zeitgeber that entrains the clock coordination of circadian rhythms, a disruption in light pathways 
to the central clock may disrupt the phase relationship between the light-dark cycle and the sleep 
cycle (Pittendrigh & Daan, 1976).  
1.1.2 Direct Pathway 
Light cues also affect sleep behavior in an acute and direct manner that does not involve 
influencing the SCN or circadian coordination. Nocturnal animals, including various species of 
rodents used in animal model studies, will decrease activity and sleep when exposed to light and 
are awoken by darkness (Benca et al., 1998). In contrast, humans and other diurnal animals 
experience an alerting effect of light and will sleep during the solar night. Although it is not clear 
what distinguishes these inverse effects of light on nocturnal versus diurnal animals, the light-
dark transition cue appears to initiate a “flip” in the switch between activity and sleep (see 
Hubbard et al., 2013).  
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The circadian rhythm of sleep was eliminated in animals with bilateral lesions in the SCN 
(Borbély, 1978; Eastman et al., 1984), but sleep and wake behaviors were retained in response to 
light stimuli and indicates a circadian-independent effect of light. Benca et al (1995) studied 
nocturnal rats in a laboratory protocol with constant light and dark pulses, a manipulation that 
disrupts the 24 hour cycle of circadian rhythms, and found that brief light exposure acutely 
suppressed motor activity and enhanced sleep whereas dark promoted wakefulness (Benca, 
Gilliland, & Obermeyer, 1995; see Saper, et al., 2005). Direct manipulations of light exposure 
and destruction of the central clock in animal models suggest that light asserts a direct influence 
on mammalian sleep and wakefulness.  
Laboratory protocols in humans have similarly revealed a direct response to light. Unlike 
nocturnal animals, humans exhibit an alerting response to light and a soporific response to 
darkness. In humans, broad-spectrum white light exposure has been shown to induce acute, dose-
dependent alerting effects such as decreases in reaction time (Lockley et al., 2006). Following 
light exposure, participants have demonstrated decreased electroencephalogram (EEG) measured 
delta-wave power density, which suggests a possible lower amount of sleep pressure build-up 
(see Badia, Myers, Boecker, Culpepper, & Harsh, 1991; Burgess, Sletten, Savic, Gilbert, & 
Dawson, 2001; Cajochen, Zeitzer, Czeisler, & Dijk, 2000; Campbell & Dawson, 1990; Daurat et 
al., 1993; Lockley et al., 2006). More so, sleep deprived participants reported decreased 
subjective sleepiness after being exposed to light (Lockley et al. 2006). In conjunction with 
animal studies, the human literature lends evidence to an additional mechanism whereby light 
not only serves as an essential zeitgeber for circadian entrainment but also initiates an acute 
alerting effect that may impact different components of sleep regulation.  
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1.2 MELANOPSIN: A CIRCADIAN PHOTOPIGMENT 
A growing body of literature suggests that the effect of light on sleep is mediated in part by 
melanopsin (see Dijk & Archer, 2009). In the primary visual pathway, the ganglion cells in the 
retina that project to the brain depend on classical photoreceptors (rods and cones) to provide 
information used in visual image formation. In contrast, the non-image forming (NIF) pathway 
consists of the classical rod and cone cells as well as another class of ganglion cells that express 
melanopsin (Provencio et al., 2000). The latter cells, known as intrinsically photosensitive retinal 
ganglion cells (ipRGCs), encode light intensity levels for non-visual functions (Berson, Dunn, & 
Takao, 2002).  
In addition to being directly photosensitive, ipRGCs receive input from rod and cone 
networks (Dacey et al., 2005) and relay light information from both the rod-cone system and 
melanopsin system to modulate sleep (Altimus et al., 2008). Clinically blind individuals have 
been shown to retain some physiological responses to light exposure (e.g. suppression of 
melatonin levels; Czeisler et al., 1995). In addition, researchers recently found that a blind 
individual had diminished pupillary light reflex (PLR) at low irradiance but sustained PLR in 
response to high-irradiance light when compared to normal sited individuals (Gooley et al., 
2012), which confirms rod and cone visual photoreceptors are not necessary for some NIF light 
responses. Guler et al (2008) more specifically investigated the role of ipRGCs in mice by 
altering the mouse melanopsin gene such that there was a reduction in melanopsin proteins 
expressed and consequently a decrease in ipRGCs. The animals retained pattern vision but had 
significantly impaired circadian photoentrainment and pupillary light reflexes (Guler et al., 
2008). Taken together, ipRGCs are important for NIF functions separate from vision including 
sleep-related light responses.  
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Melanopsin drives ipRGC photosensitivity (Berson et al., 2002; Gooley et al., 2003; 
Gamlin et al., 2007; see Berson, 2007). Melanopsin is a G-protein coupled receptor and is in the 
opsin class (Provencio et al., 2000; Provencio et al., 1998).  In the dark, melanopsin binds to 11-
cis retinaldehyde (Walker et al., 2008). Similar to other opsins, melanopsin uses 11-cis retinal as 
a light-sensing ligand or chromophore. Irradiance exposure leads the 11-cis retinal to absorb a 
photon of light and photoisomerize to all-trans retinal, which triggers a conformational change in 
melanopsin  (Walker et al., 2008). This conformation change initiates a signaling cascade and 
ultimately, to the depolarization of ipRGCs (as reviewed in Hatori & Panda, 2010; Benarroch 
2011; Hankins 2008).  
Given that ipRGCs play a critical role in NIF light responses and that melanopsin is 
needed to activate these cells, melanopsin is therefore important for sleep-related NIF functions. 
Studies in mice have shown a deficiency in melanopsin, rod, and cone cells leads to a complete 
loss of circadian photoentrainment, pupillary light reflexes, and acute light effects on sleep onset 
(Hattar et al., 2003; Lupi, Oster, Thompson, & Foster, 2008; Panda, et al., 2003). This evidence 
demonstrates that both the visual and non-visual systems are needed to drive NIF responses. 
Evidence suggesting that melanopsin plays a critical role in the non-visual system highlights its 
importance in both the circadian and non-circadian light influences on sleep.  
1.2.1 Melanopsin and Circadian Responses to Light 
It was originally believed that light effects on circadian rhythms and other NIF responses were 
mediated by the classical photoreceptors. However, mice deficient of rods and cones still 
demonstrated melatonin suppression and circadian phase-shifting responses to light exposure 
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(Freedman et al., 1999). It later became evident that an alternate photoreceptive system involving 
melanopsin (Provencio et al., 2000) drives circadian photoentrainment. 
Although the SCN does not depend solely on melanopsin for light input, melanopsin 
contributes significantly to circadian light responses (Ruby et al., 2002). Melanopsin gene 
knockout (OPN4
-/-
) mice retained the capacity to entrain to light-dark cycles (Panda et al., 2002), 
presumably through light input from rod and cone RGCs. However, OPN4
-/-
 mice that were 
exposed to brief light pulses demonstrated circadian phase-shift responses that were significantly 
lower in magnitude relative to control mice (Panda et al., 2002; Ruby et al., 2002). In contrast, 
rod and cone-deficient mice continued to demonstrate circadian photoentrainment (Barnard et 
al., 2004) with peak sensitivity at a light spectrum matching that of ipRGCs. Taken together, 
evidence suggests that although melanopsin signaling is not the sole factor involved in circadian 
photoentrainment, it is an important component.  
The influence of melanopsin on circadian sleep regulation can be explained in part by the 
melanopsin-containing retinal projections to brain structures involved in circadian 
photoentrainment. Melanopsin-expressing RGCs have been shown to project to the SCN and the 
ventral SPZ (vSPZ; Gooley et al., 2001; Gooley et al., 2003). Rats with lesions in the vSPZ 
demonstrated significant reductions in circadian regulation of sleep and locomotor activity (Lu et 
al., 2001). Given the direct projections of ipRGCs to both the SCN and vSPZ, it is possible that 
melanopsin influences sleep rhythms via this circadian pathway to both brain structures (Gooley, 
Lu, Fischer, & Saper, 2003).  
Melanopsin is not intrinsic to the functioning of the central clock itself (Do & Yau, 
2010), but a deficiency in melanopsin may disrupt necessary phototransduction to the SCN and 
subsequently disturb the cascade of biological processes involved in sleep regulation. At the 
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molecular level, the clock mechanism is comprised of a network of transcriptional-translational 
feedback loops that drive 24-hour expression patterns of core clock genes (Reppert & Weaver, 
2002). Clock genes are transcriptional regulators that produce proteins necessary to generate 
circadian rhythms within individual cells (Takahashi, 2004). In humans, various clock gene 
polymorphisms have been shown to correlate significantly with extreme diurnal preference, 
delayed sleep phase syndrome, insomnia, waking performance and early morning executive 
functions (Archer et al., 2003; Groeger et al., 2008; Jones et al., 1999; Viola et al., 2007). 
However, the significance of these candidate clock genes remains inconclusive given 
inconsistent findings and non-replication (Robilliard et al., 2002). Although a large body of 
literature continues to examine the association of clock genes with sleep characteristics, further 
efforts are needed to investigate the possible influence of genetic variation in components of 
other key pathways such as the melanopsin gene in the NIF pathway. 
1.2.2 Direct Light Responses Mediated by Melanopsin: Nocturnal Rodent 
Models   
Aside from its role in circadian photoentrainment, the melanopsin system is an important 
component of acute, direct light effects on sleep behavior. When exposed to light, wild type mice 
demonstrated acute sleep induction while OPN4
-/-
 mice failed to show the expected sleep 
response even at bright irradiances (Lupi et al., 2008). However, rod and cone-deficient mice 
demonstrated light-induced sleep responses were similar to wild type mice, suggesting that 
melanopsin alone is able to mediate acute light effects on sleep independent of the classical 
photoreceptors at least in rodless-coneless mice. In intact rodents, it is predicted that melanopsin 
also mediates acute light responses. More so, melanopsin-expressing ipRGCs have been shown 
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to project to sleep-promoting centers separate from the circadian clock such as the VLPO and the 
SC (Hannibal & Fahrenkrug, 2004; Gooley et al., 2003). A light-induced c-Fos immunoreactivity 
study showed that OPN4
-/-
 mice had attenuated, but not absent, light-induced SCN activity (Tsai 
et al., 2009), whereas there was a significant reduction in light-induced activity in the VLPO 
region and the SC (Lupi et al., 2008). These findings indicate that melanopsin may be needed for 
light-induced activation of these brain regions. The VLPO is a sleep-activating region; neurons 
from the VLPO region inhibit arousal systems in the brain that promote wakefulness (Saper et 
al., 2001). Likewise, the SC has been implicated in the light regulation of sleep (Miller, 
Obermeyer, Behan, & Benca, 1998), although direct projections from melanopsin-containing 
RGCs to the SC are sparse (Gooley et al., 2003). Taken together, these findings suggest a rodent 
pathway involving direct ipRGC projections to sleep regulating brain regions, in which 
melanopsin mediates light effects on sleep behaviors independent of the circadian pathway. 
1.3 INVESTIGATING THE ROLE OF MELANOPSIN IN HUMANS 
The aforementioned evidence that implicates melanopsin in sleep regulation is primarily based 
on findings from animal studies. However, the SCN is recognized as the primary central 
regulator of the clock network in most mammals including humans. Likewise, melanopsin 
expression is similarly localized to the retina in rodents, primates, and humans (Provencio et al., 
2000). The melanopsin system appears to be conserved in mammals evolutionarily (see Berson, 
2003). A group of intrinsically photosensitive melanopsin-expressing ganglion cells exists in 
primates (Dacey et al., 2005) while studies on human behavioral responses to light (discussed in 
detail below) suggest that this non-visual pathway is likewise conserved in humans (e.g. Gooley 
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et al., 2010; Lockley et al., 2006). For example, melanopsin has been shown to drive the 
photoresponse of ipRGCs (i.e. sustained pupillary light reflex) in both rodent and human samples 
(Berson et al., 2002; Gooley et al., 2003; Gamlin et al., 2007). Hence, inferences about the role 
of melanopsin in sleep and alertness based on rodent studies can be translated to humans.  
Although there is a paucity of literature in humans, emerging evidence suggests 
melanopsin plays a similar role in the human NIF pathway as it does in animals. While rodent 
models enable the use of genetic knockout methods and ablation technology to isolate and study 
the role of melanopsin, alternate methodological designs are required in human studies. 
Melanopsin cells demonstrate peak sensitivity to light at 480 nm wavelengths (blue light) in 
humans, leading to the use of specific light irradiances and wavelengths to derive inferences 
about melanopsin functioning in humans (e.g., Lockley et al., 2003; Gooley et al., 2010).  
In humans, physiological responses to light involved in sleep-wake regulation, such as 
circadian phase resetting and suppression of melatonin, are most sensitive to short-wavelength 
light (Brainard et al., 2001; Cajochen et al., 2005; Lockley et al., 2003). In a study exposing 
individuals to 6.5 constant hours of green (~555 nm) versus blue (~460nm) light, it was shown 
that blue light elicited a nearly constant suppression of melatonin (Gooley et al., 2010). In 
contrast, green light exposure initially elicited similar responses but after the first quarter (about 
1.5 hours), melatonin suppression lifted exponentially. These findings suggest that melanopsin 
photoreceptors provide light information continuously across long-term light exposure while 
cone photoreceptors, which show peak sensitivity to green light, are only involved in temporary 
suppression of melatonin lasting about one hour (Gooley, et al., 2010). Continuous 
phototransduction mediated by melanopsin may explain why a blind individual with no 
detectable rod or cone function demonstrated a constant level of melatonin suppression when 
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exposed to short wavelength light (~460 nm), but no melatonin suppression during long 
wavelength light exposure (Zaidi et al., 2007). Another study demonstrated that 6.5 hours of 
constant exposure to blue light more effectively decreased sleepiness and increased alertness 
relative to green light (Lockley et al., 2006). Given the peak sensitivity of melanopsin cells to 
blue light, humans appear to rely on melanopsin and the ipRGC pathway for light influences on 
sleep-wake regulation (Hankins & Lucas, 2002; Lucas et al., 2003).  
1.3.1 Melanopsin Gene (OPN4) Association Studies 
Evidence from OPN4 association studies suggests that melanopsin plays a role in human sleep 
regulation. In an initial effort to link OPN4 variants to human biological and physiological 
responses to light, Roecklein et al. (2009) examined OPN4 polymorphisms in 120 individuals 
with seasonal affective disorder (SAD) and 90 healthy controls. The authors reported that 
individuals homozygous for the minor T allele at P10L (Sherry et al., 2001) had a 5.6 times 
increased risk of SAD. The effect size was medium (d = 0.46 using the Arcsine test) and larger 
than the expected small effect size for any one gene in a disorder of complex genetics such as 
SAD. All individuals with the TT genotype were in the SAD group. Although the P10L SNP 
contributed to a SAD diagnosis in only 5% of cases, this may represent a subset within a 
heterogeneous disorder. A specific subphenotype may be characterized by related conditions 
caused in part by deficiencies in the non-visual light pathway involving melanopsin. These 
findings suggest that OPN4 variants may be associated with differences in circadian, sleep and 
behavioral responses to light.  
Given that seasonal affective disorder is thought to originate in part from circadian and 
light response abnormalities, it was hypothesized that OPN4 variants are also associated with 
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differences in sleep behaviors in healthy individuals. In a subsequent study, Roecklein et al. 
(2012) tested the association of OPN4 variants (P10L, I394T, and rs2014084) with individual 
sleep characteristics in a sample of healthy adults with no psychiatric or cardiometabolic illness 
at the time of assessment. Day length on the date of assessment, as determined by the U.S. Naval 
Observatory (2010), was included as an independent variable and tested in interaction with 
genotype. Age, gender, and depressive symptoms were included as covariates. Individuals with 
the P10L TT genotype had earlier sleep onset (p <.05) and also reported earlier chronotypes (i.e. 
morning preference for activity and sleep timing) when assessed on shorter days compared to 
individuals assessed on longer days. I394T and rs2014084 were not associated with sleep onset. 
None of the SNPs were associated with differences in wake onset or sleep duration. 
Based on this preliminary report, P10L may interact with day length to influence sleep 
onset and preferred sleep-activity times in healthy individuals in the absence of depressive 
psychopathology. This study was the first to not only examine OPN4 as a candidate gene 
associated with human sleep characteristics but also to investigate a possible gene by 
environment (i.e. photoperiod) interaction. One interpretation of these results is that P10L TT 
individuals are less receptive to the low light levels during shorter days and that melanopsin 
plays a role in shifting circadian phase and sleep timing. That the TT genotyped individuals had 
relatively earlier sleep onset times on short days but no difference in wake onset may explain the 
lack of difference in sleep duration across day lengths. The influence of other zeitgebers aside 
from light may contribute to the null association between P10L and sleep onset time. For 
example, work schedules may have served as social cues that led individuals to wake up at a 
determined time. If individuals woke up earlier than preferred, it is possible that they built up 
greater sleep debt over the day, which in turn could have induced earlier sleep times. Lastly, it is 
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important to note that sleep timing and duration were measured through the PSQI, a self-report 
questionnaire providing estimated times for average bed and wake time across the last month 
(Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). The use of only self-reported sleep times 
may have presented potential confounds from recall bias and other limitations of self-report 
questionnaires (see below). Given that this study was the first to examine the association of 
OPN4 variants and sleep characteristics, further studies are needed to replicate these findings 
with alternate measures of sleep timing in order to strengthen interpretation of these results.  
1.4 USE OF ACTIGRAPHY FOR BEHAVIORAL SLEEP MEASURES 
The present study utilized actigraphy to measure sleep timing and duration while balancing 
participant demand and ecological validity. Actigraphy, the use of accelerometer-based watch-
like devices to monitor activity, is used in sleep research to infer sleep patterns from rest and 
activity counts (Sadeh & Acebo, 2002). Polysomnography (PSG) is used as the gold standard in 
sleep research to track sleep timing, study sleep architecture, and diagnose sleep disorders. 
Polysomnography (PSGinvolves a multi-parametric, comprehensive test of various 
biophysiological processes that occur when an individual sleeps. Although thorough, PSG 
methods are expensive and typically capture individual sleep outcomes over brief time periods. 
In contrast, actigraphy is an ambulatory device that is less intrusive for participants and enables 
researchers to infer sleep-wake patterns over multiple nights while participants reside in their 
home environment. 
 15 
1.4.1 Validity of actigraphically determined sleep characteristics 
Studies comparing actigraph and PSG sleep measurements support the use of actigraphy in place 
of PSG measures for some sleep characteristics. We report here two methods of evaluating the 
reliability and validity of actigraphy: (1) agreement rates of PSG and actigraphy, and (2) the 
ability of actigraphy to detect sleep parameters in comparison to self-reported questionnaires 
(Ancoli-Israel et al., 2003).  
Various studies comparing actigraphy and PSG in healthy, non-sleep disordered subjects 
yielded >90% agreement rates (minute-by-minute agreement between the two methods) in 
distinguishing sleep and wake states, which suggests actigraphy can reliably determine when 
individuals are asleep (Sadeh, Hauri, Kripke, & Lavie, 1995). Reports for the validity of 
actigraphy vary in consistency based on the sleep variables of interest. A study on healthy 
individuals demonstrated that actigraphy was highly correlated with PSG for total sleep time (r = 
.79-.94, Jean-Louis et al., 2001). In a recent study on healthy young adults, t-test comparisons 
between two different brand activity monitors (Basic Mini-Motionlogger® and Actiwatch®) and 
PSG revealed that both actigraphs had similar reports on wake time, sleep efficiency, and total 
sleep time when compared to the PSG measures (Tonetti et al., 2008).  
While sleep questionnaires and diaries are often used in studies as the only measure of 
sleep variables given their ease of use, self-report measures alone are not consistently correlated 
with PSG or actigraphy. For instance, the Pittsburgh Sleep Quality Index (PSQI) has been shown 
to correlate with psychological symptoms and sleep disturbances recorded in daily sleep diaries, 
but not with actigraphy or PSG (Buysse et al., 2008). In a sample of healthy middle-aged adults 
(n=669), self-report and actigraphy-determined sleep duration were only modestly correlated (r= 
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0.45; Lauderdale et al., 2008). Specifically, sleep duration was on average .80 hours longer when 
measured by subjective report in comparison to actigraphy. In contrast, evidence suggests that  
actigraphy has reasonable validity and reliability when compared to PSG in assessing sleep 
timing and duration in healthy individuals with average or good sleep quality (see Sadeh, 2011) 
and is therefore a suitable method to quantify the sleep variables of interest in the current study. 
1.5 STUDY AIMS 
Here, we aimed to reexamine the relationship between variants in OPN4 and sleep timing as well 
as duration, using additional participants added to the initial study population, while improving 
upon some of the previous methodological limitations (Roecklein et al., 2012). Actigraphy was 
used as a behavioral measure of individual sleep and activity timing, and a larger sample size 
was also utilized for this replication.  
The current study implemented a hypothesis-driven approach based on a single candidate 
gene rather than a genome wide, exploratory approach. We hypothesized that variations in OPN4 
SNPs would be associated with differences in sleep onset and sleep duration in interaction with 
day length. Although Roecklein et al. (2012) previously reported no significant relationship 
between I394T and sleep characteristics, we included this polymorphism because both the P10L 
(rs2675703) and I394T SNPs (rs1079610) are missense mutations, coding region polymorphisms 
that result in a non-synonymous amino acid substitution in the melanopsin protein (NCBI 
database; Sherry 2001). We predicted that both SNPs would impact the functioning of 
melanopsin and thereby, via disruption in the light pathways, would affect sleep time and sleep 
duration. 
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Based on preliminary findings, it was predicted that P10L would be associated with 
differences in sleep onset. Specifically, we expected individuals with the TT genotype assessed 
during periods of shorter day length would demonstrate earlier sleep onset relative to those 
assessed during periods of longer day length, and relative to other genotype groups. Given that 
individuals in the sample were all adult community residents who work at least part-time, work 
schedules were expected to serve as social zeitgebers (Ehlers et al., 1988) that influence wake 
time. Hence, we predicted that wake onset would not significantly differ between genotype 
groups or across different day lengths. Given that sleep duration is thought to be regulated by an 
interaction between homeostatic (sleep debt) and circadian factors (Czeisler & Dijk, 1995; Dijk 
et al., 1999) and the role of melanopsin in circadian entrainment, it was predicted that variations 
in OPN4 would be associated with differences in sleep duration in interaction with day length. 
Despite null results in the preliminary study, we hypothesized that when assessed during shorter 
days individuals with the P10L TT genotype would demonstrate longer sleep duration relative to 
the other genotype groups. Given the null I394T results in the previous study, we predicted that 
I394T would not be associated with the sleep outcomes but exploratory analyses were conducted 
to further examine these relationships. 
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2.0  RESEARCH METHODS AND DESIGN 
The current study relied on ambulatory activity monitors to assess individual sleep 
characteristics. Participants wore an activity monitor at all times for seven days. A research 
associate made five phone calls to participants during the monitoring period to address 
equipment concerns and review instructions for all procedures. The start day of activity 
monitoring was used to determine the day length at time of assessment. Day length was recorded 
by the U.S. Naval Observatory (2010) and was used as a measure of environmental dawn and 
dusk timing. 
2.1 PARTICIPANTS 
Participants were non-Hispanic Caucasian adults (30-54 years old, N = 401) from the greater 
Pittsburgh community who volunteered for the Adult Health and Behavior II (AHAB II) project 
registry. Exclusion criteria included the use of antidepressant medications or psychoactive drugs 
that might alter their responses to questionnaires or interview measures, a history of major 
neurological disorders, schizophrenia, and/or psychotic illness. Participants who met DSM-IV 
criteria for a current mood disorder were also excluded from analyses but those who reported any 
history of a mood disorder were included (N = 42, 10%).  
. 
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2.2 MATERIALS AND ASSESSMENTS 
2.2.1 Actigraphy 
Participants wore an Actiwatch-16 activity monitor (Bend, OR: Philips Electronics) on their non-
dominant wrist for a 7-night monitoring period. Processing and scoring of the data was 
performed using validated algorithms provided in the Actiware software (v5.59; Bend, OR: 
Philips Respironics). In congruence with most actigraphy analyses, acceleration data were stored 
using 1-minute epochs (Ancholi-Israel et al., 2003). Participants were instructed to wear the 
Actiwatch continuously, day and night, and were informed that there was no need to remove it in 
the shower.  
The following measures were quantified: sleep timing (sleep onset and wake onset) and 
sleep duration. Given that the current study participants were healthy, middle aged individuals, 
wake threshold was set at the standardized medium threshold of 40 activity counts per epoch 
(Actiware v5.59). Sleep onset was determined as the beginning time point of a nighttime period 
lasting at least 10 consecutive minutes with activity counts lower than the wake threshold. Wake 
onset, the end point of the sleep interval, was designated at the time point followed by least 10 
consecutive minutes with activity counts greater than the wake threshold.  Sleep duration was 
calculated as the total time between sleep onset and wake onset. Daytime rest periods meeting 
the aforementioned criteria were not included in the present study. 
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2.2.2 Mood Disorder Diagnosis 
Individuals who met DSM-IV criteria for Major Depressive Disorder, Dysthymic Disorder, or 
Bipolar I or II Disorder (APA, 2000) were excluded from analyses. Participants underwent the 
Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998) for diagnosis of 
DSM-based Axis I disorders. The MINI was developed to allow administration by non-
clinically-trained interviewers and assesses for current presence of 17 disorders based on DSM-
IV diagnostic criteria. In a validation study of the MINI (N= 370; 308 psychiatric patients and 62 
controls)  it was found that the kappa coefficient for concordance between MINI and Structured 
Clinician Interview for DSM-IV Patient Version(SCID-P; Spitzer et al., 1992) diagnosis was .84 
for major depressive disorder (MDD; Sheehan et al., 1998). Overall, the MINI demonstrated 
high sensitivity for detecting any current diagnosis with only the kappa coefficient for current 
drug dependence falling below .5 (Sheehan et al., 1998). Sensitivity for MDD was .96. The 
specificity of the MINI in comparison to the SCID-P for all disorders was good (range: .86 to 
1.00), with .88 for MDD. In the total sample, test-retest reliability was acceptable for MDD 
(kappa coefficient: .87). 
2.2.3 Depression Symptoms  
Given that sleep disturbances may be symptoms of depression, depressive symptoms were 
included as covariates in the analyses. Subjects completed the Beck Depression Inventory – 2nd 
Edition (BDI-II) and the Center for Epidemiologic Studies - Depression Scale (CES-D; Beck, 
Steer, & Brown, 1996; Radloff, 1977). Both questionnaires were included because the BDI-II is 
the most widely used measure of the severity of depressive symptoms, while the CES-D was 
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designed to assess past week frequency of depressive symptoms. To avoid confounding sleep 
problems and depression symptoms, the total scores of each questionnaire minus the sleep items 
were used (e.g., Franzen et al., 2010). 
The BDI-II is a 21-item measure of depressive symptom severity, providing four severity 
options for each of the 21 items for participants to select (Beck et al., 1996). The BDI-II has 
demonstrated good test-retest reliability and convergent validity (Beck et al., 1996). The CES-D 
is a 20-item self-report depression symptom scale developed by the Center for Epidemiologic 
Studies (Privitera, Moynihan, Tang, & Khan, 2010). Participants report how often in the past 
week they have experienced each of 20 depression symptoms. Studies using five psychiatric 
populations and a community sample show that the CES-D is valid as a screening tool to detect 
depression symptoms, and can be used to measure change in symptom severity over time 
(Weissman, Sholomskas, Pottenger, Prusoff, & Locke, 1977). 
2.2.4 Other Covariates 
Self-reported age and gender were also included as covariates in the statistical models. Analyses 
based on sleep time are especially important to adjust for age due to age-related changes in sleep 
duration and timing (Roenneberg et al., 2007; Dijk et al., 2000). Gender was included as a 
covariate given evidence that women tend to sleep longer than men (Lindberg et al., 1997). 
2.2.5 DNA Collection and Genotyping 
DNA was collected from participants through blood samples. The region of OPN4 containing the 
containing the P10L and I394T SNPs were amplified using polymerase chain reaction methods. 
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Fluorescence polarization (FP; Chen et al., 1999) was then be used to determine was used to 
genotype the sample. 
2.3 DATA ANALYSIS 
Three different models of inheritance (additive, recessive, and dominant allele effects) were 
examined for both P10L and I394T genotypes. For each model, hierarchical linear regression 
analyses were conducted. In the first step, age, gender, CES-D and BDI-II scores (minus sleep 
items) were entered as covariates. Next, genotype and day length were entered as predictors to 
test for main effects of these variables. Finally, an interaction term derived from genotype*day 
length was entered to investigate whether differences in photoperiod would have equivalent 
influences on sleep characteristics across genotype groups.  
As detailed below, the categorical genotype groups were coded differently for each 
analysis dependent upon the model of inheritance. Day length was entered as a continuous 
variable. An interaction term was calculated as the product of day length and the genotype 
variables. Dependent variables included sleep onset, sleep offset, and sleep duration, which were 
all entered as continuous variables.  
For both P10L and I394T, the primary analyses estimated an additive model of 
inheritance. Genotype was treated as three separate categories (i.e., CC, CT, TT) for both SNPS. 
The overall model was used to predict whether there was a dose-dependent effect of genotype 
such that each additional minor allele accounted for additional variance in the dependent 
variable. Dummy coding was used in order to test for significant differences between genotype 
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groups in comparison to the reference groups, defined as the homozygous minor allele group 
(i.e., TT for P10L; CC for I394T).  
A recessive model of inheritance was estimated for both SNPs in order to examine 
whether a genotype effect is only present in individuals with a homozygous minor allele 
genotype.  Genotype was entered as a dichotomous variable, with the heterozygous and 
homozogyous major allele genotypes grouped together (i.e., P10L: TT=0, CT & CC=1).  Given 
that past studies have found only the TT homozygous genotype to be associated with SAD as 
well as earlier sleep onset (Roecklein et al., 2009; Roecklein et al., 2012), it is possible that the 
P10L SNP may have a recessive effect. 
Lastly, a dominant model of inheritance was estimated for both SNPs in order to examine 
whether any presence of a minor allele, regardless of whether there is one or two, would have an 
effect on sleep characteristics.  Genotype was entered as a dichotomous variable, with both 
homozygous minor allele and heterozygous allele coded as 1 and the homozygous major allele 
coded as 0 (i.e., P10L: CT & TT= 0, CC=1). Although evidence suggests a recessive effect for 
P10L, the functional consequences of the variant remain unknown and therefore a dominant 
model was also estimated.   
A double-loci risk score analysis was also conducted in order to examine whether a 
combination of both P10L and I394T variants would have a cumulative effect on the sleep 
characteristics of interest. It is possible that the predicted sleep variations are associated with 
polymorphisms in several loci, each with small effect sizes. The risk score was calculated as the 
sum of minor alleles an individual carries from both SNPs. For example, an individual who is 
homozygous for the T allele at P10L (TT= 2 minor alleles) and heterozygous for the C allele 
 24 
(CT= 1 minor allele) at I394T would have a risk score of 3. Risk score was entered as a 
continuous predictor variable into the hierarchical regression model.  
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3.0  RESULTS  
 
3.1 PARTICIPANT CHARACTERISTICS 
A total of 401 non-Hispanic Caucasian participants were recruited in the AHAB-II registry. Of 
these participants, 42 met criteria for a past mood disorder but none met criteria for a current 
depressive episode and were therefore included in analyses. Due to technical difficulties with the 
actiwatch or error with data import, actigraphy data was not available for some participants (n = 
15) which left a total of 386. Six participants were missing CES-D total scores, while several 
participant samples (see below) failed to genotype for either the P10L or I394I locus and were 
therefore excluded from analyses (see below). A total of 377 participants (42.43 ± 7.37 years old, 
50.4% Female) were included in the present study. Although only 374 were available for the 
P10L analyses, 377 participants were included in the I394I analyses in order to maximize the 
available data. Table 1 reports the means and standard deviations in the sample for all dependent 
variables of interest. Multivariate ANOVAs revealed that within both P10L and I394T SNPs 
there were no genotype differences (i.e., CC vs CT vs TT) between age, depressive symptoms, or 
day length during assessment (p’s >.05). There were no significant differences in gender 
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frequencies between genotype groups in either P10L (X
2
 = .45, p=.80 ) or I394T (X
2
 = 4.86, p = 
.09). 
 
 
 
Table 1. Participant Characteristics 
 
 
  Mean (SD) or % Minimum Maximum 
Years of Education 17.22 (2.79) 10 24 
Family Income  20.2%  ≥110k <10k >185k 
BMI 26.38 (4.92) 17.5 49.6 
Day Length 12.61 (1.89) hrs 9.3 hrs 15.07 hrs 
Sleep Onset 11:37 PM (1 hr 8 mins) 9:10 PM 4:31 AM 
Wake Onset 6:28 AM (1 hr 5 mins) 3:33 AM 10:33 AM 
Sleep Duration 6 hrs 51 mins (51 mins) 4 hrs 22 mins 10 hrs 27 mins 
CES-D Total 8.37 (7.99) 0 45 
CES-D*  7.65 (7.64) 0 42 
BDI-II Total 4.33 (4.50) 0 29 
BDI-II*  3.98 (4.29) 0 27 
PSQI Total 4.88 (2.58) 0 16 
Note. *Values shown are based on questionnaire scores minus sleep-related items. BMI= body mass 
index; CES-D= Center for Epidemiologic Studies Depression Scale (Radloff, 1977); BDI-II= Beck 
Depression Inventory – 2nd Edition (Beck, Steer, & Brown, 1996); PSQI= Pittsburgh Sleep Quality Index 
(Buysse, et al., 1989).  
 
3.2 GENOTYPING 
Failure rates for genotyping were less than 1.5% (P10L, n=6 (1.5%) failed to genotype, I394T 
n=3 (.7%) failed to genotype). Therefore, the total sample size for P10L analyses was n= 395 and 
for I394T n= 398. Table 2 reports the number of individuals within each genotype groups. The 
distribution of P10L and I394T genotypes satisfied Hardy-Weinberg equilibrium as determined 
using a goodness of fit chi-square test (X2 < 1, p > .05). Haploview (Barrett et al., 2005) was 
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used to calculate linkage between the two OPN4 SNPs. P10L and I394T showed strong pairwise 
linkage disequilibrium (LD), indicated by a D` value of 1 (CI: .85-1.0). More so, the logarithm of 
odds (LOD) score was 11.11 which indicates a high degree of confidence in the obtained D` 
value. Lastly, the Haploview results included a r2 value of 0.084. Although the r2 coefficient is 
surprisingly low zero between the two SNPs, the high  D` and LOD scores indicate a high 
likelihood that the two SNPs are in LD and are inherited together.   
 
 
Table 2. Genotype frequencies (n, %) 
 
 
 Genotypes 
 CC CT TT 
P10L (rs2675703) 310 (77.3%)  80 (20.0%) 5 (1.2%) 
    
I394T (rs1079610) 56 (14.0%) 198 (49.4%) 144 (35.9%) 
Note. P10L n=395 (6 failed to genotype), I394T n=398 (3 failed to genotype). A total of 377 participants 
had complete actigraphy and genotyped data.  
 
3.3 P10L 
As shown in Tables 3-5, the additive model including age, sex, depression scores, P10L 
genotype, day length, and P10L x day length interaction was not significant for predicting sleep 
onset, wake onset, or sleep duration (p’s > .05). There were no significant main effects of 
genotype, day length, or interaction effect of P10L x day length (p’s >.05).  Likewise, the 
dominant and recessive models of genetic influence revealed no significant genotype, day length, 
or interaction effect (Tables 3-5; p’s > .05). 
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Table 3. Sleep Onset is not associated with P10L across all models of inheritance 
 
 
  Model of Inheritance 
 Additive   Dominant  Recessive 
Predictor ∆R2 β   ∆R2 β   ∆R2 β 
Step 1  0.06*   0.06*   0.06*  
Covariates          
Step 2  0.01   0.01   0.00  
P10L   CC: -0.10   -0.05   0.03 
   CT: -0.16       
Day Length           0.05   0.06   0.05 
Step 3  0.00   0.00   0.00  
Day Length   CC: -0.13   -0.03   0.02 
x P10L   CT: -0.10       
Total R
2
   0.07     0.06     0.06   
Note. *p < .001, two-tailed. Values shown in Step 2 and 3 of the additive model are based on a dummy 
coded term for P10L genotype groups. Reference group is TT. 
 
 
 
Table 4. Wake Onset is not associated with P10L across all models of inheritance 
 
 
  Model of Inheritance 
 Additive   Dominant  Recessive 
Predictor ∆R2 β   ∆R2 β   ∆R2 β 
Step 1  0.05*   0.05*   0.05*  
Covariates          
Step 2  0.01   0.01   0.00  
P10L   CC: -0.03   -0.08   0.01 
   CT: -0.12       
Day Length          -0.01   -0.01   -0.01 
Step 3  0.00   0.00   0.00  
Day Length   CC: 0.34   -0.05   -0.04 
x P10L   CT: 0.13       
Total R
2
   0.06     0.06     0.05   
Note. *p ≤ .001, two-tailed. Values shown in Step 2 and 3 of the additive model are based on a dummy 
coded term for P10L genotype groups. Reference group is TT. 
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Table 5. Sleep Duration is not associated with P10L across all models of inheritance 
 
 
  Model of Inheritance 
 Additive   Dominant  Recessive 
Predictor ∆R2 β   ∆R2 β   ∆R2 β 
Step 1  0.05*   0.05*   0.05*  
Covariates          
Step 2  0.01   0.01   0.01  
P10L   CC: 0.09   -0.03   -0.02 
   CT: 0.06       
Day Length         -0.08   -0.08   -0.08 
Step 3  0.00   0.00   0.00  
Day Length   CC: 0.59   -0.03   -0.07 
x P10L   CT: 0.29       
Total R
2
   0.06     0.06     0.06   
Note. *p ≤ .001, two-tailed. Values shown in Step 2 and 3 of the additive model are based on a dummy 
coded term for P10L genotype groups. Reference group is TT. 
 
3.4 I394T 
As shown in Tables 6-8, the overall additive model including age, sex, depression scores, I394T 
genotype, day length, and I394T x day length interaction was not significant for predicting sleep 
onset, wake onset, or sleep duration (p’s > .05). There were no significant main effects or 
interaction effect of I394T and day length (p’s >.05). Null findings persisted in both the 
dominant and recessive models of genetic influence (p’s >.05) 
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Table 6. Sleep Onset is not associated with I394T across all models of inheritance 
 
 
  Model of Inheritance   
 Additive   Dominant  Recessive   
Predictor ∆R2 β   ∆R2 β   ∆R2 β   
Step 1  0.05*   0.05*   0.05*    
Covariates            
Step 2  0.00   0.00   0.00    
I394T   CT: 0.01   -0.01   -0.01   
   TT: 0.01      0.06   
Day Length          0.06   0.06      
Step 3  0.00   0.00   0.00    
Day Length   CT: 0.00   0.00   0.00   
x I394T   TT: -0.00         
Total R
2
   0.06     0.06     0.06     
Note. *p < .001. Values shown in Step 2 and 3 of the additive model are based on dummy coded terms for 
I394T genotype groups. Reference group is CC. 
 
 
Table 7. Wake Onset is not associated with I394T across all models of inheritance 
 
 
  Model of Inheritance 
 Additive   Dominant  Recessive 
Predictor ∆R2 β   ∆R2 β   ∆R2 β 
Step 1  0.05*   0.05*   0.05*  
Covariates          
Step 2  0.00   0.00   0.00  
I394T   CT: 0.08   0.02   -0.04 
   TT: 0.04       
Day Length         -0.01   -0.01   -0.01 
Step 3  0.00   0.00   0.00  
Day Length   CT: -0.05   0.07   0.04 
x I394T   TT: -0.08       
Total R
2
   0.05     0.05     0.05   
Note. *p < .05. Values shown in Step 2 and 3 of the additive model are based on dummy coded terms for 
I394T genotype groups. Reference group is CC. 
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Table 8. Sleep Duration is not associated with I394T across all models of inheritance 
 
 
  Model of Inheritance 
 Additive   Dominant  Recessive 
Predictor ∆R2 β   ∆R2 β   ∆R2 β 
Step 1  0.05*   0.05*   0.05*  
Covariates          
Step 2  0.01   0.01   0.01  
I394T   CT: 0.09   0.03   -0.04 
   TT: 0.03       
Day Length        -0.09   -0.09   -0.09 
Step 3  0.00   0.00   0.00  
Day Length   CT: -0.06   0.08   0.05 
x I394T   TT: -0.10       
Total R
2
   0.07     0.06     0.06   
Note. *p ≤ .001. Values shown in Step 2 and 3 of the additive model are based on dummy coded terms for 
I394T genotype groups. Reference group is CC. 
3.5 RISK SCORE 
The aggregate risk score did not significantly associate with differences in the sleep outcome 
variables (p’s > .05; Table 9). There was no significant interaction effect of risk score x day 
length (p >.05). 
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Table 9. Cumulative risk score not associated with sleep onset, wake onset, or sleep duration 
 
 
  Outcome Variable 
 Sleep Onset  Wake Onset  Sleep Duration 
Predictor ∆ R2 β   ∆ R2 β   ∆ R2 β 
Step 1  0.06*   0.05*   0.05*  
Covariates          
Step 2  0.00   0.00   0.01  
Risk Score   -.04   -0.06   -0.02 
Day Length   .05   -0.01   -0.08 
Step 3  0.00   0.00   0.00  
Risk Score x          
Day Length   -0.01   0.03   0.05 
Total R
2
   0.06     0.05     0.06   
 Note. *p ≤ .001.   
3.6 VARIABILITY IN NUMBER OF NIGHTS MEASURED 
Although all participants were instructed to wear the actiwatches for 7 nights, there was a range 
of collection nights among participants. Results, however, remained nonsignificant after a) 
exclusion of individuals who had less than 7 nights of data and b) the inclusion of number of 
monitoring nights as a covariate in all regression models  (p’s > .05). 
3.7 SELF-REPORTED SLEEP TIMES 
Exploratory analyses were conducted post-hoc to examine self-reported sleep information. On 
the first 4 days of the 7-day actigraphy monitoring period, participants were instructed to indicate 
via an electronic diary (ED) the times they went to bed and woke up. Wake onset was 
determined by the time at which the participant logged onto the ED device and pressed a button 
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indicating they had awoken. After this entry, participants were prompted to indicate the time at 
which they fell asleep the night before. This latter entry was used to determine sleep onset. Sleep 
duration was determined as the time elapsed between sleep onset and wake onset. Moderate 
correlations were observed between ED-based and actigraphy-derived sleep outcomes (r’s= .67-
.74). P10L, I394T, the risk score, and day length were not significantly associated with the self-
reported sleep variables (data not shown; p’s >.05). 
3.8 POST-HOC POWER ANALYSIS 
After genotype frequencies were obtained, post-hoc power analyses were conducted using the 
QUANTO 1.1 software package  (Gauderman & Morrison, 2006). The sample sizes of 377 and 
374 were used for the P10L and I394T analyses, respectively. Table 10 reports the statistical 
power calculated from the obtained effect sizes across each model of inheritance. The current 
study was insufficiently powered to detect a possible main effect of P10L, I394T or a genotype 
by day length interaction effect on sleep outcomes across each model.  The unique variance 
explained by the P10L x day length effect on sleep onset, the sleep outcome previously linked to 
P10L (Roecklein et al., 2012), was very small in both the additive and recessive models (f2= 
.020 and .016, respectively). Hence, it is possible that the null effects found in the current report 
are due to insufficient power. 
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Table 10. Post-hoc power analyses based on observed effect sizes for predictors across each 
model of genetic influence 
 
 
    Model of genetic influence 
  Predictor Additive Dominant Recessive 
P10L (n= 374)     
Sleep Onset P10L .05 .07 .05 
 P10L x Day Length .05 .07 .05 
     
Wake Onset P10L .05 .09 .05 
 P10L x Day Length .05 .12 .05 
     
Duration P10L .05 .06 .05 
 P10L x Day Length .05 .09 .07 
     
I394T (n= 377)     
Sleep Onset I394T .05 .05 .05 
 I394T x Day Length .05 .05 .05 
     
Wake Onset I394T .05 .05 .05 
 I394T x Day Length .05 .05 .05 
     
Duration I394T .05 .05 .05 
  I394T x Day Length .05 .05 .05 
 
*Note: Values shown represent power (1- β error). Power analyses were conducted based on a α-
level of .05 for a two-tailed test, sample size, minor allele frequency (MAF: P10L= .15; I394T= 
.34), and effect sizes obtained across each model of genetic influence. 
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4.0  DISCUSSION 
The present study aimed to examine whether variants in OPN4 associate with naturally occurring 
differences in sleep timing and sleep duration among healthy, middle-aged adults. We did not 
find significant associations between either P10L, I394T, or a cumulative risk score and 
individual sleep characteristics. In the present sample, day length was not associated with any of 
the three sleep outcome variables nor did day length modify the effect of either SNP. 
Based on previous findings (Roecklein et al., 2009), we had hypothesized that the P10L 
variant may have downstream impacts on the timing of sleep behavior and that this relationship 
would be modified by day length. Our inconsistent results may be in part related to differences in 
study samples. Roecklein et al. (2009) reported in a case-control study that the P10L TT 
genotype was related to risk for seasonal affective disorder (SAD), a mood disorder 
characterized by depressive episodes that occur in the fall and winter. In contrast, the current 
study excluded individuals who met criteria for depression at the time of assessment, and also 
statistically adjusted for sub-clinical depressive symptoms. Although the etiology of SAD 
remains unknown, individuals with this disorder are more likely to be phase delayed in their 
sleep cycles relative to healthy individuals (Lee et al., 2011). Hence the link between P10L and 
SAD may be driven in part by a more extreme range in sleep and activity phases that is 
underrepresented in the current healthy study sample.  
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The use of actigraphy in the current study to quantify sleep timing and duration was a 
strength in determining sleep characteristics. The previous report on sleep timing and OPN4 
relied on subjective information from the PSQI (Roecklein et al., 2012). While actigraphy is not 
perfectly correlated with PSG measures, it is a reliable and valid method to infer sleep timing 
and provides the advantage of studying free-dwelling participants that captures behavioral rather 
than subjective-based estimates of sleep patterns (Ancoli-Isreal et al., 2003). One interpretation 
of our inconsistent results may be that the previous link between P10L and PSQI-based sleep 
onset was influenced in part by estimates confounded by poor sleep quality or undetected sleep 
disorders such as insomnia. In order to examine the possible influence of methodological 
differences, a replication was conducted with the present sample. Moderate correlations were 
observed between actigraphy-derived and PSQI-based sleep outcomes (r’s= .42-.65).  Neither 
P10L nor day length, however, were significantly associated with PSQI sleep or wake time (p’s 
< 05). Our inconsistent findings may therefore not be fully explained by differences in sleep 
assessment.  
Another explanation for the present null findings may be due to a relatively lower 
percentage of individuals with the P10L TT genotype in the present sample compared to the 
previous study (Roecklein et al., 2012). A post-hoc power analyses suggest that the present 
sample was not sufficient in size to detect a possible P10L by day length interaction effect. There 
were few subjects (n = 5, 1.3%) with a TT genotype relative to the total sample (N = 374), which 
provided limited variability in day length to capture potential interaction effects. While the 
overall sample size was larger in the present study when compared to the previous report (N = 
323), the number of individuals with the P10L TT genotype remained the same (n = 5). In order 
to examine whether the null findings are in part due to insufficient power relative to the previous 
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report, analyses examining actigraphy-derived sleep measures were replicated in the previous 
sample. There were no significant associations between OPN4 variants and sleep characteristics 
when using actigraphy in the previous sample (p’s >.05). It remains unclear whether the 
previously reported association between P10L and sleep onset was spurious. A future study 
sample enriched with P10L TT genotypes may help resolve the question of power and minor 
allele frequency with this specific locus.     
Our current finding that I394I had no effect on any of the sleep phenotypes is in 
congruence with previous reports (Roecklein et al., 2009). In a recent study on Japanese students, 
Higuchi et al (2013) found an association between I394T and the pupillary light response 
(Higuchi et al., 2013). This report is the first to suggest the I394T melanopsin gene 
polymorphism has a functional role in non-image forming responses to light. The authors 
implemented a protocol, however, that exposed participants to light continuously for five 
minutes which greatly exceeds the time span used in other pupillary light response studies (e.g., 
30-60 seconds; Hattar et al., 2003; Lucas et al., 2003; Roecklein et al., 2013) and may have 
confounded results. Limitations of this study and lack of replication thus far preclude a thorough 
understanding of the functional significance of I394T.  
Several limitations in the present study include the use of average sleep and day length 
measurements without statistically adjusting for the possible influence of previous sleep and light 
exposure history. Artificial light use in modern society exposes individuals to light after sunset 
and can prolong wakefulness. Chang et al (2013) reported that the magnitude of an individual’s 
alerting response to light depends not only on absolute light exposure but also on the history of 
light exposure. In a cross-over design, the participants were exposed to either 1 lux or 90 lux 
light stimuli when they were awake for three days preceding the experimental light exposure. 
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Alerting response was measured through subjective sleepiness ratings, reaction times to an 
auditory task, and EEG determined power density/delta waves. When participants in both groups 
were exposed to 6.5 hours of 90-lux light stimuli, participants who were previously exposed to 
brighter lights demonstrated a relatively smaller and shorter alerting response relative to those 
who were exposed to dim light. The possibility that sensitization may occur as a function of light 
history introduces a more complex model wherein a cross-sectional measure of day length may 
not fully capture the effect of disruptions in the non-image forming light pathway. Lastly, sleep 
duration and sleep time are influenced not only by the circadian clock but also by history of 
sleep. The present study characterized individuals based on an average measure of sleep time and 
duration but did not control for the possibility that accumulated sleep debt over the week may 
have affected bedtime and extended sleep duration. Accelerometers with lux detection features 
can be implemented in future studies in order to measure and statistically adjust for the possible 
confounding effects of both previous light exposure and sleep debt. 
The present findings suggest that neither the P10L nor I394T melanopsin gene 
polymorphisms have a large effect on sleep timing, although it still remains possible the P10L 
TT genotype has an interaction effect with day length that we were underpowered to detect. 
Another approach that future studies can implement involves conducting a haplotype analysis. 
Haplotypes are specific combinations of alleles on a chromosome that tend to be inherited 
together in the population (Gelehrter, Collins, & Ginsburg, 1998). Single SNP association studies 
such as the current report assume the tested SNP is either itself a disease locus or is in high 
linkage disequilibrium (LD) with an unidentified disease locus. Commonly inherited or 
correlated alleles are usually in high LD with one another. Conducting only a SNP association 
analysis may not account for other significant loci that are in low LD with the SNPs of interest. 
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A haplotype analysis may identify potentially significant combinations of OPN4 alleles while 
eliminating the need to test for all possible combination of genotypes and thereby controls the 
degrees of freedom and increases statistical power (Clark, 2004). Given recent findings that 
CLOCK gene variants are linked with sleep duration (Allebrandt et al. 2010), future studies 
should also utilize a multi-locus risk score approach to investigate a possible cumulative effect of 
melanopsin and clock gene variants that may independently be too small to detect in single SNP 
association studies.   
While a growing animal literature suggests melanopsin plays an integral role in circadian 
photoentrainment and downstream behavioral and physiological processes, there remains a 
limited understanding of its significance in humans. The current non-significant results warrant 
investigation of 1) other variations in the melanopsin gene upstream regulatory region, 2) other 
genes involved in the clock network that may impact circadian entrainment of the sleep-wake 
cycle, and 3) further study of the role of melanopsin in more proximal behavioral measures of 
non-image forming functions in humans. 
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